VOYA Investment Management Portfolio holdings
AUM
$100B
This Quarter Return
+17.51%
1 Year Return
+30.07%
3 Year Return
+120.64%
5 Year Return
+214.86%
10 Year Return
+564.47%
AUM
$100B
AUM Growth
+$100B
(+12%)
Cap. Flow
+$1.36B
Cap. Flow
% of AUM
1.35%
Top 10 Holdings %
Top 10 Hldgs %
26.3%
Holding
2,806
New
155
Increased
1,259
Reduced
1,080
Closed
127
Top Buys
| 1 |
Microsoft
MSFT
|
$1.03B |
| 2 |
Boston Scientific
BSX
|
$514M |
| 3 |
Caterpillar
CAT
|
$387M |
| 4 |
Cisco
CSCO
|
$366M |
| 5 |
Walt Disney
DIS
|
$363M |
Top Sells
| 1 |
Salesforce
CRM
|
$504M |
| 2 |
Palantir
PLTR
|
$326M |
| 3 |
CrowdStrike
CRWD
|
$291M |
| 4 |
Bank of America
BAC
|
$277M |
| 5 |
Cadence Design Systems
CDNS
|
$264M |
Sector Composition
| 1 | Technology | 33.81% |
| 2 | Financials | 9.82% |
| 3 | Consumer Discretionary | 8.14% |
| 4 | Healthcare | 8.11% |
| 5 | Industrials | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Rimini Street
RMNI
$401M
| $59.6K | ﹤0.01% | 15,796 | – | – |
|
2477
United States Antimony
UAMY
$549M
| $59.5K | ﹤0.01% | +25,475 | New | +$59.5K |
|
2478
Corvus Pharmaceuticals
CRVS
$428M
| $59.1K | ﹤0.01% | +14,774 | New | +$59.1K |
|
2479
Kaltura
KLTR
$246M
| $59K | ﹤0.01% | 29,375 +961 | +3% | +$1.93K |
|
2480
ADC Therapeutics
ADCT
$345M
| $58.7K | ﹤0.01% | 21,911 -362 | -2% | -$970 |
|
2481
Monte Rosa Therapeutics
GLUE
$296M
| $58.4K | ﹤0.01% | 12,958 +1,345 | +12% | +$6.07K |
|
2482
Aldeyra Therapeutics
ALDX
$351M
| $58.3K | ﹤0.01% | 15,226 +1,302 | +9% | +$4.99K |
|
2483
WideOpenWest
WOW
$437M
| $57.4K | ﹤0.01% | 14,143 | – | – |
|
2484
Olaplex Holdings
OLPX
$954M
| $57K | ﹤0.01% | 40,689 +2,669 | +7% | +$3.74K |
|
2485
Perspective Therapeutics
CATX
$250M
| $56.9K | ﹤0.01% | 16,546 +1,129 | +7% | +$3.88K |
|
2486
Codexis
CDXS
$246M
| $56.4K | ﹤0.01% | 23,124 +1,225 | +6% | +$2.99K |
|
2487
Cardiff Oncology
CRDF
$140M
| $56.3K | ﹤0.01% | 17,885 +1,781 | +11% | +$5.61K |
|
2488
Open Lending Corp
LPRO
$249M
| $56.3K | ﹤0.01% | 29,031 | – | – |
|
2489
Esperion Therapeutics
ESPR
$448M
| $55.7K | ﹤0.01% | 56,580 +3,814 | +7% | +$3.75K |
|
2490
Candel Therapeutics
CADL
$318M
| $55.6K | ﹤0.01% | +10,981 | New | +$55.6K |
|
2491
3D Systems Corporation
DDD
$295M
| $55.5K | ﹤0.01% | 36,061 | – | – |
|
2492
Rocket Pharmaceuticals
RCKT
$354M
| $55.1K | ﹤0.01% | 22,508 +3,151 | +16% | +$7.72K |
|
2493
Arq
ARQ
$330M
| $55K | ﹤0.01% | +10,249 | New | +$55K |
|
2494
Editas Medicine
EDIT
$231M
| $55K | ﹤0.01% | 25,003 +457 | +2% | +$1.01K |
|
2495
Getty Images
GETY
$763M
| $54.8K | ﹤0.01% | 32,985 +5,030 | +18% | +$8.35K |
|
2496
Sight Sciences
SGHT
$213M
| $54.7K | ﹤0.01% | 13,248 +2,831 | +27% | +$11.7K |
|
2497
Vuzix
VUZI
$164M
| $54K | ﹤0.01% | +18,476 | New | +$54K |
|
2498
OmniAb
OABI
$230M
| $53.2K | ﹤0.01% | 30,572 +2,809 | +10% | +$4.89K |
|
2499
Verastem
VSTM
$569M
| $52.9K | ﹤0.01% | 12,758 +2,180 | +21% | +$9.05K |
|
2500
Definitive Healthcare
DH
$419M
| $52.8K | ﹤0.01% | 13,542 -1,201 | -8% | -$4.68K |
|